{"id":"W3089125873","doi":"10.1016/j.annonc.2020.08.960","title":"821P Timing of adverse events during maintenance treatment with rucaparib for recurrent ovarian cancer in the phase III ARIEL3 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Internal medicine; Placebo; PARP inhibitor; Population; Phases of clinical research; Ovarian cancer; Surgery; Cancer; Clinical trial; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001750733,0.0003495769,0.001063199,0.0001425134,0.0001897238,0.0007537762,0.0003689417,0.0004616012,0.002232191],"category_scores_gemma":[0.001759423,0.0002254838,0.001331114,0.0003871641,0.0001732297,0.0004613545,0.000229711,0.001804916,0.0003363265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004663648,"about_ca_system_score_gemma":0.0005167365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006520035,"about_ca_topic_score_gemma":0.0018635,"domain_scores_codex":[0.9994325,0.0002635264,0.0000308603,0.0001002694,0.0000841608,0.00008868271],"domain_scores_gemma":[0.9988987,0.0003924202,0.0003940731,0.000100789,0.00006208338,0.0001519427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5838374,0.002802503,0.1226854,0.001601145,0.01134715,0.0005790986,0.0001768354,0.004966071,0.02044691,0.0007213187,0.01165281,0.2391834],"study_design_scores_gemma":[0.1256901,0.1220757,0.7052826,0.0002569009,0.01088559,0.001679103,0.000171737,0.004799153,0.006353036,0.001296482,0.02138848,0.0001211697],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984999,0.008218405,0.0004788135,0.0004025989,0.0001178794,0.0001280368,0.0024243,0.00007213039,0.003158896],"genre_scores_gemma":[0.9950951,0.001427389,0.0002377122,0.0003929245,0.00008076705,0.0001083655,0.001539987,0.00002498263,0.001092777],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002232191,"threshold_uncertainty_score":0.009258866,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1877396312442508,"score_gpt":0.4642549456489057,"score_spread":0.2765153144046549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}